These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35148580)

  • 1. Role of Betatrophin and Inflammation Markers in Type 2 Diabetes Mellitus, Prediabetes and Metabolic Syndrome.
    Onalan E; Bozkurt A; Gursu MF; Yakar B; Donder E
    J Coll Physicians Surg Pak; 2022 Mar; 32(3):303-307. PubMed ID: 35148580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Betatrophin Levels of Subjects Classified with Normal, Impaired, and Diabetic Glucose Tolerance, and Subjects with Impaired Fasting Glucose.
    Ozyazgan S; Onal B; Kurtulus EM; Uzun H; Akkan G; Konukoglu D
    Horm Metab Res; 2017 Jun; 49(6):434-439. PubMed ID: 28351091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating betatrophin in healthy control and type 2 diabetic subjects and its association with metabolic parameters.
    Al-Daghri NM; Rahman S; Sabico S; Amer OE; Wani K; Ansari MG; Al-Attas OS; Kumar S; Alokail MS
    J Diabetes Complications; 2016; 30(7):1321-5. PubMed ID: 27311786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Betatrophin Correlates with Triglycerides and Postprandial Glucose among Different Glucose Tolerance Statuses--A Case-Control Study.
    Gao T; Jin K; Chen P; Jin H; Yang L; Xie X; Yang M; Hu C; Yu X
    PLoS One; 2015; 10(8):e0133640. PubMed ID: 26247824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased circulating full-length betatrophin levels in drug-naïve metabolic syndrome.
    Liu D; Li S; He H; Yu C; Li X; Liang L; Chen Y; Li J; Li J; Sun X; Tian H; An Z
    Oncotarget; 2017 Mar; 8(11):17510-17517. PubMed ID: 28177922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Serum ANGPTL8/Betatrophin and Cartonectin/CTRP3 Levels in Diabetic and Non-Diabetic Retinopathy.
    Pehlivan V; Gursu MF; Citak O; Onalan E; Yakar B; Donder E
    J Coll Physicians Surg Pak; 2023 Jan; 33(1):66-72. PubMed ID: 36597238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between serum betatrophin levels and the first-phase of glucose-stimulated insulin secretion.
    Liu D; Qu H; Wang H; Duan Y; Liu F; Feng Z; Deng H
    Obes Res Clin Pract; 2018; 12(Suppl 2):9-15. PubMed ID: 27554132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients.
    Hu H; Sun W; Yu S; Hong X; Qian W; Tang B; Wang D; Yang L; Wang J; Mao C; Zhou L; Yuan G
    Diabetes Care; 2014 Oct; 37(10):2718-22. PubMed ID: 25024395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance.
    Chen X; Lu P; He W; Zhang J; Liu L; Yang Y; Liu Z; Xie J; Shao S; Du T; Su X; Zhou X; Hu S; Yuan G; Zhang M; Zhang H; Liu L; Wang D; Yu X
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E96-100. PubMed ID: 25303484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between Bethatrophin and 25(OH)D Concentrations in a Group of Subjects With Normal and Impaired Glucose Metabolism.
    Turkon H; Yalcın H; Toprak B; Demirpençe M; Yaşar HY; Colak A
    Exp Clin Endocrinol Diabetes; 2017 Mar; 125(3):147-150. PubMed ID: 26910534
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
    Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
    Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating betatrophin is elevated in patients with type 1 and type 2 diabetes.
    Yamada H; Saito T; Aoki A; Asano T; Yoshida M; Ikoma A; Kusaka I; Toyoshima H; Kakei M; Ishikawa SE
    Endocr J; 2015; 62(5):417-21. PubMed ID: 25753914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating betatrophin/ANGPTL8 levels correlate with body fat distribution in individuals with normal glucose tolerance but not those with glucose disorders.
    Zheng J; Liu J; Hong BS; Ke W; Huang M; Li Y
    BMC Endocr Disord; 2020 Apr; 20(1):51. PubMed ID: 32299395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of betatrophin with youth onset type 2 diabetes among Asian Indians.
    Gokulakrishnan K; Manokaran K; Pandey GK; Amutha A; Ranjani H; Anjana RM; Mohan V
    Diabetes Res Clin Pract; 2015 Jul; 109(1):71-6. PubMed ID: 25981323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postload hyperglycemia is associated with increased subclinical inflammation in patients with prediabetes.
    Colak A; Akinci B; Diniz G; Turkon H; Ergonen F; Yalcin H; Coker I
    Scand J Clin Lab Invest; 2013 Aug; 73(5):422-7. PubMed ID: 23767858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome.
    Fu J; Hou C; Li L; Feng D; Li G; Li M; Li C; Gao S; Li M
    Cardiovasc Diabetol; 2016 Oct; 15(1):142. PubMed ID: 27716289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between circulating microRNAs 486, 146b and 15b and serum betatrophin levels in obese; type 2 diabetic and non-diabetic children.
    Mohany KM; Al Rugaie O; Al-Wutayd O; Al-Nafeesah A; Saleem TH
    BMC Endocr Disord; 2020 Sep; 20(1):145. PubMed ID: 32988370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum betatrophin concentrations are significantly increased in overweight but not in obese or type 2 diabetic individuals.
    Guo K; Lu J; Yu H; Zhao F; Pan P; Zhang L; Chen H; Bao Y; Jia W
    Obesity (Silver Spring); 2015 Apr; 23(4):793-7. PubMed ID: 25776943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating betatrophin in relation to metabolic, inflammatory parameters, and oxidative stress in patients with type 2 diabetes mellitus.
    Hassan AB; Salih SF; Hassan II; Saadi FS; Abdulah DM; Ahmed IH; Taher SM; Khaleel BB
    Diabetes Metab Syndr; 2019; 13(1):458-463. PubMed ID: 30641744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum levels of betatrophin in pancreatic cancer-associated diabetes.
    Susanto H; Liu TY; Chen CC; Purnomo JD; Chen SF; Wang CH
    Oncotarget; 2016 Jul; 7(27):42330-42339. PubMed ID: 27276680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.